NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04/12/2017
- Dialyze Direct Expands Dialysis in Skilled Nursing Facilities Posted 08/14/2019
- HHS Secretary Alex Azar Obtains Baxter Commitment to Workers Posted 08/14/2019
- AAKHI Aligns with DaVita Vision for Patient Care Posted 07/15/2019
- Baxter Prepares to Bring the Benefits of PD to More Patients Posted 07/15/2019
- Fresenius Heads Home and Looks Forward to AAKHI Initiatives Posted 07/15/2019